VitaSpring Biomedical Co. Ltd.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.

Profit Margin

VitaSpring Biomedical Co. Ltd. (OTC:VSBC): Profit margin
2017 0 -108
2018 16.23K -6.37K -39.27%
2019 17.18K -22.39K -130.36%
2020 15.14K 24.29K 160.44%
2021 248.2K -425.38K -171.39%
2022 5.61M 1.26M 22.52%
2023 0 0

VSBC Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
05.61M248.2K15.14K17.18K16.23K0
Cost of revenue
03.54M136K13.44K3.46K4.88K0
Gross profit
02.06M112.2K1.69K13.71K11.34K0
Operating exp.
Research and development
0000000
Selling and marketing
0000000
Total operating expenses
0584.53K536.91K21.18K36.11K17.71K108
Operating income
01.48M-425.38K-19.48K-22.39K-6.37K-45
Other income (expenses), net
0-2.36K-67226.40K0152.51K
Income before tax
01.48M-425.38K6.91K-22.39K-6.37K-108
Income tax expense
0217.10K-672-17.37K01-52.62K
Net income
01.26M-425.38K24.29K-22.39K-6.37K-108
Earnings per share
Basic EPS
00.00-0.000.00-0.00-0.00-0.00
Diluted EPS
00.00-0.000.00-0.00-0.00-0.00
Data sourceData sourceData sourceData sourceData source